Page last updated: 2024-10-31

mitoxantrone and Hypocalcemia

mitoxantrone has been researched along with Hypocalcemia in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffiths, KD1
Parry, DH1

Other Studies

1 other study available for mitoxantrone and Hypocalcemia

ArticleYear
Hypomagnesaemia and hypocalcaemia after treatment with mitoxantrone.
    BMJ (Clinical research ed.), 1988, Aug-13, Volume: 297, Issue:6646

    Topics: Female; Humans; Hypocalcemia; Magnesium; Middle Aged; Mitoxantrone

1988